Airway Effects of Tiotropium in Patients With COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

January 1, 2018

Study Completion Date

January 1, 2018

Conditions
COPDLUNG DISEASES, OBSTRUCTIVE
Interventions
COMBINATION_PRODUCT

Handihaler-Tiotropium 18 mcg untrained

We are looking at the untrained used of Handihaler

COMBINATION_PRODUCT

Handihaler-Tiotropium 18 mcg trained

We are looking at the trained use of Handihaler after 14 days treatment

COMBINATION_PRODUCT

Respimat-Tiotropium 5 mcg trained

we are looking at the trained use of Respimat after 14 days treatment

Trial Locations (1)

SW36LY

Asthma Lab, Royal Brompton Hospital, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Imperial College London

OTHER

NCT02683668 - Airway Effects of Tiotropium in Patients With COPD | Biotech Hunter | Biotech Hunter